Literature DB >> 21126648

ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Neena S Abraham, Mark A Hlatky, Elliott M Antman, Deepak L Bhatt, David J Bjorkman, Craig B Clark, Curt D Furberg, David A Johnson, Charles J Kahi, Loren Laine, Kenneth W Mahaffey, Eamonn M Quigley, James Scheiman, Laurence S Sperling, Gordon F Tomaselli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21126648     DOI： 10.1016/j.jacc.2010.09.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  45 in total

Review 1.  2011 ACCF/AHA focused update of the guidelines for the management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 Guideline): highlights for the clinician.

Authors:  Nanette K Wenger
Journal:  Clin Cardiol       Date:  2011-12-06       Impact factor: 2.882

Review 2.  Novel antiplatelet therapies.

Authors:  Luke Kim; Konstantinos Charitakis; Rajesh V Swaminathan; Dmitriy N Feldman
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

3.  Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2.

Authors:  Xingyang Yi; Zhao Han; Qiang Zhou; Wen Cheng; Jing Lin; Chun Wang
Journal:  Clin Appl Thromb Hemost       Date:  2016-09-16       Impact factor: 2.389

Review 4.  Antiplatelet drug interactions with proton pump inhibitors.

Authors:  Stuart A Scott; Aniwaa Owusu Obeng; Jean-Sébastien Hulot
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-11-09       Impact factor: 4.481

Review 5.  Association between Bacterial Infection and Peripheral Vascular Disease: A Review.

Authors:  Jacek Budzyński; Joanna Wiśniewska; Marek Ciecierski; Anna Kędzia
Journal:  Int J Angiol       Date:  2015-03-23

6.  Management for non-variceal upper gastrointestinal bleeding in elderly patients: the experience of a tertiary university hospital.

Authors:  Koichiro Kawaguchi; Hiroki Kurumi; Yohei Takeda; Kazuo Yashima; Hajime Isomoto
Journal:  Ann Transl Med       Date:  2017-04

Review 7.  Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Authors:  Nicola Ferri; Alberto Corsini; Stefano Bellosta
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

8.  Proton-pump inhibitor use is associated with lower urinary magnesium excretion.

Authors:  Jeffrey H William; Rachel Nelson; Najwah Hayman; Kenneth J Mukamal; John Danziger
Journal:  Nephrology (Carlton)       Date:  2014-12       Impact factor: 2.506

9.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

Review 10.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.